Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBIT Margin (2016 - 2026)

Phibro Animal Health has reported EBIT Margin over the past 14 years, most recently at 13.46% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 520.0% year-over-year to 13.46%; the TTM value through Dec 2025 reached 11.53%, up 415.0%, while the annual FY2025 figure was 8.52%, 328.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 13.46% at Phibro Animal Health, down from 14.09% in the prior quarter.
  • Over five years, EBIT Margin peaked at 14.09% in Q3 2025 and troughed at 0.31% in Q3 2023.
  • A 5-year average of 8.11% and a median of 8.13% in 2022 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: plummeted -620bps in 2023 and later surged 729bps in 2025.
  • Year by year, EBIT Margin stood at 9.58% in 2021, then plummeted by -32bps to 6.48% in 2022, then dropped by -3bps to 6.28% in 2023, then surged by 31bps to 8.26% in 2024, then surged by 63bps to 13.46% in 2025.
  • Business Quant data shows EBIT Margin for PAHC at 13.46% in Q4 2025, 14.09% in Q3 2025, and 8.9% in Q2 2025.